The Board of Directors of Celltrion, Inc. has authorized a buyback plan on March 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
194,600 KRW | +0.10% | +2.96% | -3.42% |
04-24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
04-17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.42% | 29.55B | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B | |
+18.74% | 11.58B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion, Inc. authorizes a Buyback Plan.